{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-093979","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2026-08-26T20:15:42+00:00","discovered_at":"2026-08-26T20:17:12.180924+00:00","generated_at":"2026-08-26T20:17:20.252231+00:00","sec_items":["1.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Jasper Therapeutics receives Nasdaq delisting notice for equity shortfall","bullets":["On Aug 21, 2026, Nasdaq notified Jasper it fails $2.5M stockholders' equity requirement under Rule 5550(b)(1).","Company has 45 days (until Oct 5, 2026) to submit a compliance plan to regain compliance.","Plans to seek stockholder approval to convert Non-Voting Convertible Preferred Stock to boost equity.","If plan accepted, Nasdaq may grant up to 180-day extension; otherwise hearing process available.","No immediate effect on listing; common stock continues trading on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-093979","json":"https://secwatch.observer/filing/0001213900-26-093979.json","markdown":"https://secwatch.observer/filing/0001213900-26-093979.md","text":"https://secwatch.observer/filing/0001213900-26-093979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026093979/0001213900-26-093979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026093979/ea0303509-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-26T20:17:20.252231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}